AzTrials
AzTrials

InsomniaiTAP-VNCT03804788

The Insomnia Treatment and Problems Study for Veterans

A study testing Cognitive Behavioral Therapy for Insomnia and Sleep Hygeine in people with Insomnia and Alcohol; Harmful Use, run by University of Missouri-Columbia at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

This project aims to evaluate improvement of insomnia as a mechanism of improvement in alcohol use outcomes. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Insomnia, Alcohol; Harmful Use
What is being tested?
Cognitive Behavioral Therapy for Insomnia and Sleep Hygeine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
71 participants
Where
1 siteUnited States
Study dates
4 Apr 2019to 30 Sep 2023
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Veteran deployed for military service after September 11, 2001
  • 1+ heavy drinking episode (4/5+ drinks in 2 hours for women/men) in past 30 days
  • DSM-5 and research diagnostic criteria for Insomnia Disorder

Who cannot join

  • Inability to provide informed consent
  • Cognitive impairment
  • Contraindications for CBT-I (mania or seizure disorder)
  • Untreated sleep disorder requiring more than behavioral treatment for insomnia
  • Engagement in overnight shift work at baseline
  • Care of a child under 1 year of age
Show all 9Show fewer
  • Severe or untreated psychiatric disorder that requires immediate clinical attention
  • Current behavioral treatment for insomnia or alcohol use
  • Initiation of sleep medication in the past 6 weeks

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Missouri-Columbia

    Columbia, Missouri, 65212

Other trials in United States

About this study

Official title: The Impact of Insomnia Treatment on Heavy Alcohol Use Among Returning Veterans

This project aims to evaluate improvement of insomnia as a mechanism of improvement in alcohol use outcomes.

Read the detailed description

More than half of returning Veterans who screen positive for hazardous drinking report clinically significant symptoms of insomnia. In turn, insomnia symptoms have been associated with increased risk of alcohol-related problems, perhaps due to insomnia-related impairments in executive functioning, negative emotionality, and craving. The proposed project aims to examine improvements in insomnia as a mechanism for improvement in alcohol use among heavy-drinking Veterans with insomnia. Forty-four returning Veterans who report heavy drinking (≥4/5 drinks per occasion for women/men) and have insomnia based on DSM-5 and research diagnostic criteria will participate in a randomized pilot trial. Participants will be randomly assigned to receive personalized normative alcohol feedback in the context of one of two treatment conditions: CBT-I (n = 22) or a sleep hygiene education control (SH; n = 22). Outcomes will be assessed at the end of the active intervention period (6 weeks), mid-treatment (after 3 sessions), and at 3 months post-intervention. Outcomes of interest include insomnia severity, total wake time, sleep quality, drinking quantity/frequency, alcohol-related consequences, executive functioning, negative affect, emotion regulation, craving for alcohol, and use of alcohol as a sleep aid.

Being tested
Cognitive Behavioral Therapy for Insomnia, Sleep Hygeine
Keywords
alcohol, drinking, sleep, insomnia, veteran
Medical subject headings
Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive Behavioral Therapy for InsomniaBehavioural

    Also called (CBT-I)

    Cognitive Behavioral Therapy for Insomnia (CBT-I). Participants assigned to the CBT-I condition will attend 1-hour individual sessions of CBT-I once a week for five weeks. A sixth week of treatment will be included - and scheduled for the same date as the post-treatment assessment - if the participant and research team agree that it would be beneficial (e.g., if a participant has difficulty grasping cognitive therapy concepts). Consistent with clinical guidelines (Schutte-Rodin, Broch, Buysse, Dorsey, \& Sateia, 2008), treatment will include stimulus control (e.g., limit use of bed to sleep or sexual activity, get out of bed if lying awake for more than 20 minutes), sleep restriction (limit time in bed to amount of time spent sleeping on a typical night), sleep hygiene (e.g., avoid exercise within 2 hours of bedtime, create cool and dark sleep environment), relaxation training, and cognitive restructuring.

  • Sleep HygeineBehavioural

    All participants will receive a one-page handout on sleep hygiene that includes personalized normative feedback on their alcohol use. This is the only intervention that participants assigned to the Sleep Hygiene condition will receive and is consistent with what may be expected as standard care in a doctor's visit with a primary care physician.

Study groups in NCT03804788
Study groupRoleWhat they receive
CBT-IExperimentalIndividual Cognitive Behavioral Therapy for Insomnia (CBT-I) delivered once a week for six (6) weeks.
Receives: Behavioral: Cognitive Behavioral Therapy for Insomnia; Behavioral: Sleep Hygeine
Sleep HygieneActive comparatorSleep hygiene handout delivered once to all participants.
Receives: Behavioral: Sleep Hygeine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recruitment

    Number of eligible participants who enrolled in the study

    Measured: Assessed at baseline

  2. Retention

    Number of participants who complete all treatment sessions

    Measured: Assessed at post-treatment (week 6)

  3. Drinking Quantity

    Assessed using Daily Drinking Questionnaire. Participants report the number of standard drinks consumed on each day of a typical week in the past month (on Monday, Tuesday, Wednesday, etc). Responses for each day are then summed to calculate a total "drinks per week" variable, where higher scores indicate more standard drinks.

    Measured: Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.

  4. Alcohol-related Consequences

    Assessed using the Brief Young Adult Alcohol Consequences Questionnaire, which asks participants to indicate (yes/no) which of 24 consequences they have experienced in the past month. Responses range from 0 to 24, with greater scores indicating more consequences.

    Measured: Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.

  5. Insomnia Symptoms

    Assessed using Insomnia Severity Index (ISI). ISI scores from 0 to 28, with higher scores indicating more severe insomnia.

    Measured: Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.

  6. Sleep Quality

    On daily sleep diaries, participants reported sleep quality on a scale from 0 (very poor) to 4 (very good). Higher scores indicate better sleep quality.

    Measured: Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.

  7. Sleep Efficiency

    Daily sleep diaries were used to calculate the amount of time that participants spent sleeping out of all the time they spent in bed. Values from 0 to 100, with higher scores indicating better sleep efficiency. The treatment goal is 85%.

    Measured: Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.

  8. Client Satisfaction

    Assessed using the 8-item Client Satisfaction Questionnaire. Participants rate their satisfaction with insomnia treatment on a scale from 1 (poor) to 4 (excellent). Scores were summed and then divided by the number of items to create a meaningful standardized score. Higher scores indicate greater satisfaction.

    Measured: Mean score at post-treatment (week 6).

Secondary outcomes (6)
  1. Delay Discounting

    Assessed using the Monetary Choice Questionnaire (MCQ). Participants indicate if they would rather receive a smaller amount of money now or a greater amount of money in a specified amount of time (e.g., 100 days, 2 days). The MCQ is scored using a logarithmic subject-specific discount rate (k variable). K values typically fall between 0.0 and 0.5, with higher values indicating a preference for smaller, immediate rewards over larger, delayed reward ("delay discounting").

    Measured: Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.

  2. Negative Affect

    Assessed using the Positive and Negative Affect Schedule. Participants indicate using a 1 (not at all) - 5 (extremely) scale to indicate to what extent they feel negative emotions. The final score is the sum of the ten negative emotions/feelings. Higher scores indicate more negative affect.

    Measured: Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.

  3. Emotion Regulation

    Assessed using the Difficulties in Emotion Regulation Scale (DERS-16). Scores range from 0 to 64, with higher scores indicating more difficulties with emotion regulation.

    Measured: Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.

  4. Alcohol Craving

    Assessed using the Penn Alcohol Craving Scale (PACS). Scores range from 0 to 30, with higher scores indicating more craving.

    Measured: Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.

  5. Percentage of Days Using Alcohol to Help With Sleep

    Participants completed 2 weeks of sleep diaries assessing use of alcohol to help with sleep. Number of days reporting use of alcohol as a sleep aid was divided by the number of diaries completed to indicate the percentage of diary days they used alcohol as a sleep aid. Higher scores indicate more frequent use of alcohol as a sleep aid.

    Measured: Primary analyses will measure between-group change at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.

  6. Percentage of Days Using Sleep Medication

    Participants completed 2 weeks of sleep diaries assessing use of sleep medication. Number of days reporting use of sleep medication was divided by the number of diaries completed to indicate the percentage of diary days they used a sleep medication. Higher scores indicate more frequent use of sleep medication.

    Measured: Primary analyses will measure between-group change at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jan 2019
  2. Study start4 Apr 2019
  3. Primary completion30 Sep 2023
  4. Study completion30 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Subjects will be randomized to receive sleep hygiene or to participate in sessions of individual Cognitive Behavioral Therapy for Insomnia (CBT-I).
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
71 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03804788
Sponsor's protocol ID
2014239
Other IDs
K23AA026895
Acronym
iTAP-V
Status last verified
Sep 2026
First submitted
9 Jan 2019
Last updated
11 Sep 2026
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Miller MB, Carpenter RW, Shoemaker SD, Moskal KR, Borsari B, Pedersen ER, Bartholow BD, Steinley D, McCrae CS. Cognitive behavioral therapy for insomnia among heavy-drinking veterans: a randomized pilot trial. Sleep Adv. 2025 Jun 10;6(2):zpaf037. doi: 10.1093/sleepadvances/zpaf037. eCollection 2025 Apr.

    PubMed 40575624

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in